By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ProSciento, Inc. (Formerly Known As Profil Institute for Clinical Research, Inc.) 

855 3rd Avenue
Suite 3340
Chula Vista  California  91911  U.S.A.
Phone: 619-427-1300 x100 Fax: 619-427-1307


SEARCH JOBS

ProSciento is a full scope clinical R&D services provider, exclusively focused on diabetes, NASH and obesity. The company has completed more than 250 metabolic clinical projects, representing more early phase type 1 and type 2 diabetes clinical trials than any other U.S. provider.1 The team has supported the development of more than 15 metabolic drugs and devices on the market worldwide, and, in 2015, facilitated one of the year's largest early-stage licensing deals.

YEAR FOUNDED:

2003

LEADERSHIP:

CEO: Marcus Hompesch

CDO: Christian Weyer

COO: Linda Morrow

CFO: Markus Hofmann

JOBS:

Please click here for job opportunities.

FOLLOW PROSCIENTO:




Key Statistics


Email:
Ownership: Private

Web Site: ProSciento
Employees:
Symbol: 
 









Company News
ProSciento And OWL Metabolomics Form Strategic Collaboration Focused On Accelerating NAFLD/NASH Clinical Trial Recruitment 6/7/2017 7:44:49 AM
ProSciento Appoints Dr. Kelvin Logan, Former Executive At INC Research (INCR) And Quintiles, To Its Board Of Directors 5/30/2017 10:03:41 AM
Profil Institute for Clinical Research, Inc. Release: Research Institute Announces Corporate Name Change To ProSciento, Inc. To Reflect Expanded Metabolism-Focused Clinical R&D Services 1/10/2017 11:26:14 AM
Profil Institute for Clinical Research, Inc. And Antaros Medical Form Strategic Alliance To Incorporate Advanced Functional Imaging Techniques Into Cardiometabolic Clinical Research 9/14/2016 6:57:28 AM
Profil Institute for Clinical Research, Inc. And Shenzhen HighTide Biopharmaceutical Announce A Strategic Partnership Focused On The Development Of New Therapies For Diabetes And NAFLD/NASH 7/28/2016 6:29:46 AM
Profil Institute for Clinical Research, Inc. And LMC Diabetes Launch Strategic Partnership To Conduct Cross-Border Multi-Site Trials In Diabetes And Metabolism 6/10/2016 9:39:22 AM
Profil Institute for Clinical Research, Inc. And mySugr Collaborate To Advance Evidence-Based Clinical Validation Of Diabetes Mhealth Solutions 6/9/2016 9:48:34 AM
Profil Institute for Clinical Research, Inc. Appoints Dr. Christian Weyer As President And Chief Development Officer 12/1/2015 6:59:21 AM
Profil Institute for Clinical Research, Inc. Appoints Meryl Wiernik As Senior Director Of Clinical Operations 11/24/2015 6:34:22 AM
Profil Institute for Clinical Research, Inc. Unites Leading Experts In Biomarker Discovery And Clinical Research To Address The Medical Challenges Of NAFLD/NASH 10/28/2015 10:43:38 AM
123
//-->